Karyopharm shareholders approve reverse stock split and share increase

Karyopharm Therapeutics Inc.

Approved increase in authorized capital stock to 805M shares (common to 800M).
Approved reverse stock split at ratio 1:5 to 1:15; board to decide timing and exact ratio by Feb 28, 2025.
Reverse split: 74.8M votes for, 20.0M against; share increase: 71.6M for, 23.4M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.